Simulations Plus Inc is a leading provider of advanced software and consulting services for the pharmaceutical and biotechnology industries. The company specializes in modeling and simulations that aid in drug discovery and development, including pharmacokinetics and pharmacodynamics. By offering powerful tools and platforms, Simulations Plus enables researchers to predict and analyze drug behavior and interactions, ultimately enhancing the efficiency and success rate of developing new therapeutics. Their innovative solutions support various stages of the drug development process, helping clients streamline their research efforts, reduce costs, and bring new medications to market more effectively. Read More
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the following investor events in September:
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Simulations Plus (SLP) To Contact Him Directly To Discuss Their Options
NEW YORK, NY - August 26, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).
NEW YORK, NY - August 26, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, NY - August 22, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, NY - August 20, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).
NEW YORK, NY - August 18, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws.
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP) investors concerning the Company’s possible violations of the federal securities laws.
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Law Offices of Howard G. Smith announces an investigation on behalf of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP) on behalf of investors concerning the Company’s possible violations of federal securities laws.
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
